Virtu Financial’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $430K | Buy |
+11,817
| New | +$430K | 0.02% | 624 |
|
|
2021
Q1 | – | Sell |
-14,202
| Closed | -$1.97M | – | 1942 |
|
|
2020
Q4 | $1.97M | Buy |
+14,202
| New | +$1.97M | 0.21% | 109 |
|
|
2019
Q4 | $321K | Buy |
+7,521
| New | +$321K | 0.03% | 647 |
|
|
2019
Q2 | – | Sell |
-6,229
| Closed | -$432K | – | 1766 |
|
|
2019
Q1 | $432K | Buy |
+6,229
| New | +$432K | 0.02% | 620 |
|
|
2018
Q4 | – | Sell |
-19,617
| Closed | -$1.5M | – | 1900 |
|
|
2018
Q3 | $1.5M | Buy |
19,617
+15,922
| +431% | +$1.22M | 0.09% | 224 |
|
|
2018
Q2 | $284K | Buy |
+3,695
| New | +$284K | 0.02% | 1193 |
|
|
2018
Q1 | – | Sell |
-7,372
| Closed | -$342K | – | 2472 |
|
|
2017
Q4 | $342K | Buy |
+7,372
| New | +$342K | 0.02% | 1149 |
|